Pharma Stock News - InMed Pharmaceuticals Inc.'s (NASDAQ: INM) INM-901 Demonstrates Unique Pharmacological Effects in Alzheimer's Disease in Preclinical Proof-of-Concept Studies
Pharma Stock News - InMed Pharmaceuticals Inc.s (NASDAQ: INM) INM-901 Demonstrates Unique Pharmacological Effects in Alzheimers Disease in Preclinical Proof-of-Concept Studies
United Kingdom British Columbia Eric Hsu Colin Clancy Eli Lilly Neurodegenerative Disease Program Progress
Source: investorideas.com